| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| PPP1R2C |
O14990
|
PPP1R2C family member C
|
Enzyme modulator
|
|
0.478 |
0.846 |
| MIR17HG |
Q75NE6
|
miR-17-92a-1 cluster host gene
|
|
|
0.483 |
0.808 |
| LINC02605 |
|
long intergenic non-protein coding RNA 2605
|
|
|
0.490 |
0.769 |
| RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
| MIR18A |
|
microRNA 18a
|
|
|
0.520 |
0.846 |
| LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
| P2RX5-TAX1BP3 |
|
P2RX5-TAX1BP3 readthrough (NMD candidate)
|
|
|
0.588 |
0.769 |
| IS1 |
|
Adolescent idiopathic scoliosis
|
|
|
0.593 |
0.615 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
| SYN2 |
Q92777
|
synapsin II
|
Cellular structure
|
|
0.653 |
0.577 |
| LOC110806262 |
|
solute carrier family 6 member 4 gene promoter
|
|
|
0.626 |
0.423 |
| H3P19 |
|
H3 histone pseudogene 19
|
|
|
0.631 |
0.577 |
| STIN2-VNTR |
|
serotonin transporter intronic VNTR enhancer
|
|
|
0.636 |
0.538 |
| TDGF1P3 |
P51864
|
teratocarcinoma-derived growth factor 1 pseudogene 3
|
Calcium-binding protein
|
|
0.631 |
0.500 |
| MAFD2 |
|
major affective disorder 2
|
|
|
0.641 |
0.731 |
| MDD1 |
|
Major depressive disorder
|
|
|
0.682 |
0.308 |
| MAPT-AS1 |
|
MAPT antisense RNA 1
|
|
|
0.711 |
0.269 |
| LINC00461 |
|
long intergenic non-protein coding RNA 461
|
|
|
0.736 |
0.423 |
| IGHG1 |
P01857
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
|
0.700 |
0.500 |
| LINC01122 |
|
long intergenic non-protein coding RNA 1122
|
|
|
0.821 |
0.269 |
| DISC2 |
|
disrupted in schizophrenia 2
|
|
|
0.716 |
0.192 |